首页 | 本学科首页   官方微博 | 高级检索  
检索        

GEMOX方案治疗晚期胰腺癌的临床疗效
引用本文:鲁明骞,许新华,苏进,薛峰,李道俊,易芳,文采虹,王杰.GEMOX方案治疗晚期胰腺癌的临床疗效[J].江苏医药,2011,37(3).
作者姓名:鲁明骞  许新华  苏进  薛峰  李道俊  易芳  文采虹  王杰
作者单位:三峡大学第一临床医学院肿瘤研究所,湖北省宜昌市中心人民医院肿瘤内科,湖北宜昌市,443003
摘    要:目的评价GEMOX方案治疗晚期胰腺癌患者的临床疗效。方法 42例晚期胰腺癌患者给予吉西他滨800~1200mg/m2,静脉滴注30min,d1、d8;奥沙利铂135mg/m2,静脉滴注2h,d1。2周期后评价化疗效果。无效病例终止化疗;有效病例继续行原方案化疗4~6周期,然后评价其疗效和安全性。结果部分缓解(PR)10例,稳定(SD)11例,进展(PD)21例;有效率(RR)23.8%,1年生存率32.6%。无化疗相关死亡病例。主要不良反应有骨髓抑制、恶性、呕吐、外周末梢神经毒性等。结论 GEMOX方案治疗晚期胰腺癌患者安全有效率,不良反应可以耐受。

关 键 词:胰腺癌  化疗  

Clinical outcomes of GEMOX regimen in treatment of patients with advanced pancreatic cancer
LU Mingqian,XU Xinhua,SU Jin,et al..Clinical outcomes of GEMOX regimen in treatment of patients with advanced pancreatic cancer[J].Jiangsu Medical Journal,2011,37(3).
Authors:LU Mingqian  XU Xinhua  SU Jin  
Institution:LU Mingqian,XU Xinhua,SU Jin,et al.Institute of Oncology,Three Gorges University First Medical College,Yichang 443003,CHINA
Abstract:Objective To evaluate the efficacy and toxicity of GEMOX regimen in treatment of the patients with advanced pancreatic cancer.Methods Forty-two patients with advanced pancreatic cancer were treated with gemcitabine 800-1200mg/m2 for 30 minutes D1 and D8,Oxaliplatin 135mg/m2 for 2 hours a,D1.Clinical efficacy was evaluated two weeks later,on the basis of which,chemotherapy was stopped in the patients without effectiveness or GEMOX regimen was continued for 4 to 6 weeks in those with active response to the ch...
Keywords:Pancreatic carcinoma  Chemotherapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号